Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003149375 | SCV003837149 | uncertain significance | not provided | 2022-08-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004978798 | SCV005576566 | uncertain significance | Inborn genetic diseases | 2024-10-29 | criteria provided, single submitter | clinical testing | The c.3190G>A (p.G1064S) alteration is located in exon 22 (coding exon 22) of the DYNC2H1 gene. This alteration results from a G to A substitution at nucleotide position 3190, causing the glycine (G) at amino acid position 1064 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |